Published in J Natl Cancer Inst on August 18, 1999
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09
Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell (2010) 3.34
Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro Oncol (2006) 1.86
Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy. Br J Cancer (2007) 1.67
Brain cancer incidence trends in relation to cellular telephone use in the United States. Neuro Oncol (2010) 1.63
Incidence of gliomas by anatomic location. Neuro Oncol (2007) 1.55
Microglia/macrophages promote glioma progression. Glia (2010) 1.51
Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010. Cancer (2014) 1.37
A 16-gene signature distinguishes anaplastic astrocytoma from glioblastoma. PLoS One (2014) 1.26
Acute and fractionated irradiation differentially modulate glioma stem cell division kinetics. Cancer Res (2012) 1.25
In vivo detection of c-Met expression in a rat C6 glioma model. J Cell Mol Med (2007) 1.25
Brain cancer propagating cells: biology, genetics and targeted therapies. Trends Mol Med (2009) 1.23
Annexin A2 promotes glioma cell invasion and tumor progression. J Neurosci (2011) 1.23
Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors. Neuro Oncol (2008) 1.15
Akt signaling pathway: a target for radiosensitizing human malignant glioma. Neuro Oncol (2010) 1.14
Brain cancer mortality in the United States, 1986 to 1995: a geographic analysis. Neuro Oncol (2004) 1.11
Metabolism and brain cancer. Clinics (Sao Paulo) (2011) 1.10
Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells. Mol Cell Biol (2002) 1.10
Combining cytotoxic and immune-mediated gene therapy to treat brain tumors. Curr Top Med Chem (2005) 1.09
Tumor initiating cells in malignant gliomas: biology and implications for therapy. J Mol Med (Berl) (2009) 1.01
Metabolic alterations: a biomarker for radiation-induced normal brain injury-an MR spectroscopy study. J Magn Reson Imaging (2009) 1.00
Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme. Neuro Oncol (2010) 1.00
Therapeutic effect of neural stem cells expressing TRAIL and bortezomib in mice with glioma xenografts. Cancer Lett (2011) 0.97
The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence. Expert Rev Neurother (2015) 0.96
Dual inhibition of sodium-mediated proton and calcium efflux triggers non-apoptotic cell death in malignant gliomas. Brain Res (2010) 0.95
Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment. Cancer J (2012) 0.94
Exploratory Visual Analysis of statistical results from microarray experiments comparing high and low grade glioma. Cancer Inform (2007) 0.93
Sperm protein 17 is expressed in human nervous system tumours. BMC Cancer (2006) 0.93
The membrane targeted apoptosis modulators erucylphosphocholine and erucylphosphohomocholine increase the radiation response of human glioblastoma cell lines in vitro. Radiat Oncol (2006) 0.92
Brain metastasis from an unknown primary, or primary brain tumour? A diagnostic dilemma. Curr Oncol (2009) 0.91
Re: Brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst (1999) 0.91
Phosphoproteome of human glioblastoma initiating cells reveals novel signaling regulators encoded by the transcriptome. PLoS One (2012) 0.91
Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model. J Control Release (2007) 0.90
Diagnostic segregation of human brain tumours using Fourier-transform infrared and/or Raman spectroscopy coupled with discriminant analysis. Anal Methods (2012) 0.89
Survival analysis of F98 glioma rat cells following minibeam or broad-beam synchrotron radiation therapy. Radiat Oncol (2011) 0.89
Trends in childhood brain tumor incidence, 1973-2009. J Neurooncol (2013) 0.88
uPAR and cathepsin B inhibition enhanced radiation-induced apoptosis in gliomainitiating cells. Neuro Oncol (2012) 0.86
Are pediatric brain tumors on the rise in the USA? Significant incidence and survival findings from the SEER database analysis. Childs Nerv Syst (2013) 0.86
Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors. Mol Ther (2013) 0.85
Molecular magnetic resonance imaging approaches used to aid in the understanding of angiogenesis in vivo: implications for tissue engineering. Tissue Eng Part A (2010) 0.85
Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway. Mol Cancer (2013) 0.84
Increasing incidence of childhood tumours of the central nervous system in Denmark, 1980-1996. Br J Cancer (2006) 0.83
Adult brain cancer in the U.S. black population: a Surveillance, Epidemiology, and End Results (SEER) analysis of incidence, survival, and trends. Med Sci Monit (2014) 0.82
Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry. Br J Cancer (2013) 0.82
Antitumor activity of TRAIL recombinant adenovirus in human malignant glioma cells. J Korean Med Sci (2005) 0.81
MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons. Int J Mol Sci (2014) 0.81
Measuring the optical characteristics of medulloblastoma with optical coherence tomography. Biomed Opt Express (2015) 0.80
The Treatment of Malignant Gliomas. Curr Treat Options Neurol (2005) 0.79
The role of semaphorins and their receptors in gliomas. J Signal Transduct (2012) 0.79
Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy. Cell Death Dis (2014) 0.79
Nanotechnology applications for glioblastoma. Neurosurg Clin N Am (2012) 0.78
Down-regulation of HSP60 Suppresses the Proliferation of Glioblastoma Cells via the ROS/AMPK/mTOR Pathway. Sci Rep (2016) 0.78
Identifying family members who are likely to perceive benefits from providing care to a person with a primary malignant brain tumor. Oncol Nurs Forum (2012) 0.78
Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma. Oncotarget (2015) 0.77
Re: Brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst (2000) 0.76
High Erk-1 activation and Gadd45a expression as prognostic markers in high risk pediatric haemolymphoproliferative diseases. J Exp Clin Cancer Res (2009) 0.76
Glioblastoma specific antigens, GD2 and CD90, are not involved in cancer stemness. Anat Cell Biol (2015) 0.76
Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells. Oncotarget (2016) 0.75
Assessment of Glioma Response to Radiotherapy Using Multiple MRI Biomarkers with Manual and Semiautomated Segmentation Algorithms. J Neuroimaging (2016) 0.75
The Evangelismos hospital central nervous system tumor registry: Analysis of 1414 cases (1998-2009). Surg Neurol Int (2013) 0.75
Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model. Mol Cancer Ther (2016) 0.75
Unique spectral markers discern recurrent Glioblastoma cells from heterogeneous parent population. Sci Rep (2016) 0.75
Gene expression by simian virus 40 large T antigen-induced medulloblastomas in mice. Neural Regen Res (2012) 0.75
Brain cancer mortality in an agricultural and a metropolitan region of Rio de Janeiro, Brazil: a population-based, age-period-cohort study, 1996-2010. BMC Cancer (2014) 0.75
Flexible ligated ruthenium(II) self-assemblies sensitizes glioma tumor initiating cells in vitro. Oncotarget (2017) 0.75
Snail homolog 1 is involved in epithelial-mesenchymal transition-like processes in human glioblastoma cells. Oncol Lett (2017) 0.75
Is mortality due to primary malignant brain and other central nervous system tumors decreasing? J Neurooncol (2017) 0.75
Apparent diffusion coefficient in differentiation of pediatric posterior fossa tumors. Jpn J Radiol (2017) 0.75
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst (2000) 133.74
Development of a comorbidity index using physician claims data. J Clin Epidemiol (2000) 19.31
Racial differences in the treatment of early-stage lung cancer. N Engl J Med (1999) 9.65
Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57
Agreement between questionnaire data and medical records. The evidence for accuracy of recall. Am J Epidemiol (1989) 6.46
Cellular-telephone use and brain tumors. N Engl J Med (2001) 5.57
The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev (1999) 5.49
Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA (1996) 5.31
Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA (2001) 5.28
Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol (2001) 4.80
Mitochondrial abnormalities in Alzheimer's disease. J Neurosci (2001) 4.39
Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst (1998) 4.32
Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst (2001) 4.26
Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell (2001) 4.21
New ages for the last Australian megafauna: continent-wide extinction about 46,000 years ago. Science (2001) 3.91
Early care limitations independently predict mortality after intracerebral hemorrhage. Neurology (2007) 3.73
Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group. J Natl Cancer Inst (1997) 3.61
Multidimensional model of racial identity: a reconceptualization of African American racial identity. Pers Soc Psychol Rev (1998) 3.54
Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst (1996) 3.52
Natural selection of life history attributes: an analytical approach. Theor Popul Biol (1974) 3.50
Copernicus revisited: amyloid beta in Alzheimer's disease. Neurobiol Aging (2001) 3.48
Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res (1997) 3.41
Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. JAMA (1999) 3.37
Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst (1999) 3.35
Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst (1999) 3.19
Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA (2000) 3.18
Clues to cancer etiology from studies of farmers. Scand J Work Environ Health (1992) 2.98
Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer (1998) 2.94
Projected costs of ischemic stroke in the United States. Neurology (2006) 2.93
Upright tilt testing in evaluating syncope: a comprehensive literature review. Am J Med (1994) 2.90
RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci (1999) 2.86
Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature (1997) 2.86
Clinical trial designs for cytostatic agents: are new approaches needed? J Clin Oncol (2001) 2.82
4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem (1997) 2.80
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
Late mortality after surgery for peptic ulcer. N Engl J Med (1982) 2.73
Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging (1997) 2.69
A population-based case-control study of childhood leukemia in Shanghai. Cancer (1988) 2.59
Aging and cancer in America. Demographic and epidemiologic perspectives. Hematol Oncol Clin North Am (2000) 2.58
Oxidative damage in Alzheimer's. Nature (1996) 2.55
Ricinoleic acid biosynthesis and triacylglycerol assembly in microsomal preparations from developing castor-bean (Ricinus communis) endosperm. Biochem J (1991) 2.53
Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci (2000) 2.52
Cancer incidence and mortality, 1973-1995: a report card for the U.S. Cancer (1998) 2.48
Attributable risk: advantages of a broad definition of exposure. Am J Epidemiol (1994) 2.45
Rheumatoid arthritis and cancer risk. Eur J Cancer (1996) 2.44
Direction of reading of the genetic message. J Biol Chem (1965) 2.43
Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst (1999) 2.38
Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States. BMJ (2012) 2.38
Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol (1996) 2.36
Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst (2000) 2.35
Serum transaminases during salicylate therapy. Br Med J (1971) 2.34
Association between childhood acute lymphoblastic leukemia and use of electrical appliances during pregnancy and childhood. Epidemiology (1998) 2.33
Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol (1999) 2.31
Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst (1994) 2.31
The rational clinical examination. Does this patient have strep throat? JAMA (2000) 2.30
Lead exposure and children's intellectual performance. Int J Epidemiol (1987) 2.30
Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. Br Med J (Clin Res Ed) (1982) 2.24
Cancer statistics by race and ethnicity. CA Cancer J Clin (1998) 2.18
National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health (1997) 2.17
Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers. J Biol Chem (1990) 2.16
Body mass index and all-cause mortality in a nationwide US cohort. Int J Obes (Lond) (2006) 2.14
Etiology of brain tumors in adults. Epidemiol Rev (1995) 2.13
Identification of agrin, a synaptic organizing protein from Torpedo electric organ. J Cell Biol (1987) 2.11
Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation. J Cell Biol (2000) 2.11
Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med (1995) 2.07
Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst (1997) 2.06
Ancient hematoma: a unifying concept for a post-traumatic lesion mimicking an aggressive soft tissue neoplasm. Mod Pathol (1997) 2.04
A systematic review of the precision and accuracy of dose measurements in photon radiotherapy using polymer and Fricke MRI gel dosimetry. Phys Med Biol (2002) 1.99
Flat feet in children. BMJ (1990) 1.94
Undertreatment of glaucoma among black Americans. N Engl J Med (1991) 1.93
Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. Med Care (2000) 1.90
The relative survival rate. Cancer (1995) 1.89
Factors protecting children living in disharmonious homes: maternal reports. J Am Acad Child Adolesc Psychiatry (1990) 1.86
Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis. Proc Natl Acad Sci U S A (1995) 1.85
Long-term cancer patient survival in the United States. Cancer Epidemiol Biomarkers Prev (1998) 1.83
Are children living near high-voltage power lines at increased risk of acute lymphoblastic leukemia? Am J Epidemiol (2000) 1.82
Variable management of soft tissue sarcoma: regional audit with implications for specialist care. Br J Surg (1997) 1.81
Surgical resection of primary soft-tissue sarcoma. Incidence of residual tumour in 95 patients needing re-excision after local resection. J Bone Joint Surg Br (1996) 1.80
The relationship between racial identity and self-esteem in African American college and high school students. J Pers Soc Psychol (1998) 1.80
Anterior spinal tuberculosis: paraplegia following laminectomy. Ann R Coll Surg Engl (1989) 1.80
Household solvent exposures and childhood acute lymphoblastic leukemia. Am J Public Health (2001) 1.80
Evidence that childhood acute lymphoblastic leukemia is associated with an infectious agent linked to hygiene conditions. Cancer Causes Control (1998) 1.78
Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med (1994) 1.77
Patterns of occurrence of the leukaemias. Eur J Cancer (1995) 1.77
On the estimation of survival. Semin Surg Oncol (1994) 1.76
Determination of microgram quantities of protein in the presence of milligram levels of lipid with amido black 10B. Anal Biochem (1985) 1.75
The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06. N Engl J Med (1995) 1.74
Determination of lung cancer incidence in the elderly using Medicare claims data. Am J Epidemiol (1993) 1.74
A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut (2001) 1.72
The saturated vapor pressure of desflurane at various temperatures. Anesth Analg (1996) 1.72
Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci U S A (1994) 1.71
Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol (1997) 1.71
Paternal cigarette smoking and the risk of childhood cancer among offspring of nonsmoking mothers. J Natl Cancer Inst (1997) 1.69
Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide. Nat Med (1995) 1.69
Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem (2001) 1.68
Using structured implicit review to assess quality of care in the Program of All-Inclusive Care for the Elderly (PACE) J Am Geriatr Soc (2000) 1.68